Quick answer: American Screening Corp advises: yes, some Robitussin products can cause a preliminary positive. Robitussin DM contains dextromethorphan, which can cross-react on PCP (25 ng/mL cutoff) and sometimes opiate (2,000 ng/mL) immunoassay screens, generally for 1 to 3 days. Codeine-containing cough syrups test opiate-positive. Every positive screen is preliminary; confirm by GC/MS or LC-MS/MS.
- Guaifenesin-only Robitussin products are not expected to cause a positive on standard panels.
- Dextromethorphan (DXM) products can produce a false-positive PCP result, and occasionally an opiate result, on an immunoassay.
- Any non-negative screen should be treated as preliminary and sent for laboratory confirmation before action is taken.
Does Robitussin show up on a drug test?
It depends on the active ingredient, not the brand name. Robitussin is a family of cough and cold products with different formulas. Check the Drug Facts label for the active ingredients before drawing any conclusion.
Need drug tests for your clinic, program or workplace?
American Screening Corp has supplied FDA-cleared, CLIA-waived tests at wholesale pricing since 2004. Popular options:
Ordering 100+ tests? Request volume pricing.
Instant urine screens are immunoassays. They detect a drug class by antibody binding, not by identifying each molecule. A structurally similar compound can occasionally bind and produce a preliminary positive.
Which Robitussin ingredients matter?
Dextromethorphan (DM and Max formulas)
Dextromethorphan is an over-the-counter cough suppressant. Its metabolite, dextrorphan, is known to cross-react with some PCP immunoassays. Less often it is reported on opiate immunoassays. Cross-reactivity varies by manufacturer and by dose, so one device may read negative while another reads preliminary positive.
Guaifenesin
Guaifenesin is an expectorant. It is not a target of standard drug-screen panels, so a guaifenesin-only product should not trigger a result on a 5-panel to 18-panel cup.
Codeine (cough syrups with codeine)
Codeine is an opioid. Syrups containing it are a true source of opiate-positive results, not a false positive. These products are controlled and, in most states, require a prescription. Ask the donor for the prescription and review it through your medical review process.
Other ingredients
Combination cold products can add decongestants or antihistamines. Some immunoassays can react to certain decongestants, such as pseudoephedrine, on amphetamine screens. Always review the full ingredient list.
Cutoff levels and detection windows
The cutoffs below are the initial test cutoffs commonly used in urine screening. The HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs (SAMHSA) set the federal framework, and DOT 49 CFR Part 40 governs DOT-regulated testing. Windows are general estimates and vary with dose, metabolism and hydration.
| Ingredient | Panel affected | Typical screening cutoff | General window | Result type |
|---|---|---|---|---|
| Dextromethorphan | PCP (sometimes opiates) | PCP 25 ng/mL; opiates 2,000 ng/mL | About 1 to 3 days | Possible cross-reaction; preliminary only |
| Guaifenesin | None on standard panels | Not applicable | Not applicable | Not expected |
| Codeine | Opiates | 2,000 ng/mL | About 1 to 3 days | True positive for codeine; review prescription |
What should a buyer do with a preliminary positive?
Treat the device result as screening information only. Our drug test cups and drug test dip cards are screening devices. Confirmation by GC/MS or LC-MS/MS laboratory testing distinguishes dextromethorphan from PCP and codeine from other opioids.
- Record the result exactly as read, within the time window in the device instructions.
- Ask the donor to disclose medications, including over-the-counter products, in writing.
- Retain the specimen under proper chain of custody.
- Send the specimen for GC/MS or LC-MS/MS confirmation.
- Have a qualified reviewer assess the confirmed result before any decision.
Checklist for clinics, courts, and employers
- Collect a medication disclosure form before testing.
- Document lot numbers and read times for each device.
- Make confirmation testing the written policy for every non-negative screen.
- Do not take adverse action on a screening result alone.
- Keep policy aligned with your state statutes and, for DOT-regulated employees, 49 CFR Part 40.
- Use consistent procedures across all donors.
Who needs to plan for this?
Treatment centers, probation offices and staffing firms see over-the-counter cough medicine questions regularly. A short written policy saves time and limits disputes. Employers that pair testing with pre-employment screening can coordinate with our sister division, Reveal Background, for background checks. For bulk, private label or lab confirmation questions, contact American Screening Corp.
Frequently asked questions
Can Robitussin cause a false positive for PCP?
Yes. Dextromethorphan in Robitussin DM can cross-react on some PCP immunoassays at the 25 ng/mL cutoff. The result is preliminary. Confirm by GC/MS or LC-MS/MS.
Will Robitussin cause a positive for opiates?
Dextromethorphan-only products rarely do. Robitussin products containing codeine will cause an opiate-positive result at the 2,000 ng/mL cutoff.
How long does dextromethorphan stay in urine?
Generally about 1 to 3 days after a typical dose. Dose, metabolism and hydration change this, so treat it as an estimate only.
How do we confirm a preliminary positive?
Send the retained specimen to a laboratory for GC/MS or LC-MS/MS testing. A qualified reviewer should then evaluate the confirmed result and medication disclosures.
Sources
- eCFR: 49 CFR Part 40, Procedures for Transportation Workplace Drug and Alcohol Testing Programs
- SAMHSA: Workplace Drug Testing and Mandatory Guidelines
- NIDA: Dextromethorphan (DXM)
This article is general information, not legal or medical advice.
